KR20170136929A - Sanyang ginseng weaning food manufactured by this manufacturing method - Google Patents

Abstract

The present invention relates to weaning food using wild cultivated ginseng and a manufacturing method thereof. The present invention may be characterized in that soybean fiber is 0.5-1.2 wt% and oat fiber is 0.2-0.8 wt% with respect to the total weight. More preferably, the present invention may further contain 6-15 wt% of refractory maltodextrin and 0.04-0.1 wt% of magnesium chloride (MgCl26H2O). In addition, the manufacturing method of weaning food using wild cultivated ginseng comprises: (1) a first step of adding 0.1-0.3 wt% of potassium citrate and 0.06-0.10 wt% of sodium citrate as an acidity regulator to 70-80 wt% of purified water, and adjusting the pH to 5.5-7.5; (2) a second step of further adding 1-10 wt% of casein sodium, 1-12 wt% of isolated soybean protein, 2.0-4.5 wt% of repressed oil, 0.2-2.5 wt% of medium chain fatty acid (MCT-oil), and 0.01-0.5 wt% of sorbitan fatty acid ester as an emulsifier; and (3) a third step of further adding 0.5-1.2 wt% of soybean fiber, 0.2-0.8 wt% of oat fiber, 6-15 wt% of maltodextrin, and 0.04-0.1 wt% of magnesium chloride (MgCl26H2O).

Description

[0001] Description [0002] SANYANG GINSENG WEANING FOOD MANUFACTURED BY THIS MANUFACTURING METHOD [0003]

The present invention relates to a baby formula using a goat ginseng and a method for preparing the same, and more particularly, to a baby formula using a goat ginseng and a method for producing the baby formula using the ginseng ginseng.

At present, the food process in Korea is distinguished from general food by "12. Food for special medical purposes ", and the target of use is infants and elderly people who are health vulnerable groups. And pregnant women. It can be seen that foodstuffs for special use in the US, special-purpose foods in Japan, and special nutrients in the EU are used in countries all over the world.

In Chapter 12 of Food Code 12, the detailed items are divided into "12-6 Foods for special medical purposes, etc." as "food for normal use, digestion, absorption or metabolism, Or food that has been manufactured and processed so that it can be supplied to them through oral or landscape food for the purpose of replacing part or all of the meal of a person with a special nutritional requirement physiologically due to clinical condition " have.

Special medicinal food, etc. In order to provide balanced nutrients to the patients in food, it is manufactured and processed by adjusting the nutrients. There is a balanced nutritional formula for patients, which can replace some or all of the patient's meals. In addition, patients with diabetes or hyperglycemia Diabetic patient food that can be substituted for some or all of the meals of these patients. Nutrients needed to provide balanced nutrients to people with chronic kidney disease The nutritional ingredients are hydrolyzed and hydrolyzed to provide a balanced supply of nutrients for patients with intestinal diseases in which digestion and absorption of food nutrients for kidney patients, which can be substituted for some or all of the meals of these patients, Manufactured or processed to replace some or all of Hydrolyzed food for the disease Patients for the congenital metabolic disease for the sick is the food for the congenital metabolic disease which is produced and processed by removing or restricting the non metabolizable ingredient in the body or by adding other necessary ingredients, Refers to a disease in which a harmful substance is accumulated or deficient in a necessary substance due to a biochemical metabolic defect at the time of birth of a gene abnormality, such as an inability of a metabolic enzyme or a transfer defect of a substance. Examples thereof include phenylketonuria, hypothyroidism, (0 to 36 months) and physiological nutrition (normal or infantile), such as diabetes mellitus, homocystinuria, colorectal diabetes mellitus, congenital adrenal hyperplasia and other metabolic abnormalities such as amino acids, organic acids, carbohydrates, fats and fatty acids and minerals. Prepared for nutritional purposes for premature babies or premature babies with significantly different requirements Special-purpose foods for infants and children The viscosity-enhancing food for dysmenorrhea is used to reduce the risk of difficulty in food intake or airway aspiration. It is used to increase viscosity by adding to solid or liquid foods. have.

Currently, there is a market for specialty medicinal foods that patients can use as part or all of a meal. (1) Vitamin A, B1, B2, B6, C, D, E, niacin and folic acid are above the indicated amount. (2) Crude protein, crude fat, calcium, Iron, and zinc. However, since it is known that the composition of protein and lipid and the type of carbohydrate and dietary fiber affect the condition of the patient, Balanced nutritional drink can help to control diarrhea.

Meanwhile, dietary fiber (dietary fiber) refers to an indigestible polymer fiber component that is not degraded by the digestive enzymes of the body. It is distributed mainly on the cell wall of the plant cell or on the skin of the plant seed. Dietary fiber was not absorbed by the body and was therefore considered not to be of nutritional value. However, recently, interest in functional food has been heightened, and it is called "the seventh nutrient" because it recognizes a physiological function different from six nutrients such as carbohydrate, protein, fat, vitamin, mineral and water. Recently, many studies on the utilization of dietary fiber have been made.

Hereinafter, patent documents relating to the present invention will be described.

First, KR 2011-0116344 (a composition for promoting bowel function and promoting bowel activity containing dietary fiber, oligosaccharide, and lactic acid-producing bacillus) exists. Compared with the present invention, the content of dietary fiber affects bowel movements, but it is not a concept of patient nutrition that the present invention defines.

Second, there is KR 2010-0120962 (soy / milk and lactic acid bacteria fermented with soybean / vegetable nutrition balance formula, patient formula and preparation method thereof). Compared with the present invention, the constituents are different.

Third, KR 2000-0060079 (diarrhea and fecal incontinence enteral nutrition) exists. The aim of improving diarrhea in patients is similar to the present invention, but unlike the present invention, there is a great difference in that insoluble dietary fiber is used instead of water soluble dietary fiber.

The conventional patient nutrition formula has been pointed out in that (i) the high incidence of diarrhea; (ii) the possibility of disease deterioration due to dehydration and nutritional imbalance in high risk patients.

Although it is clear that the general formula and the patient nutrition formula should be different from each other in composition and ratio, studies on the components and ratios in which the beneficial effect is recognized have not been studied so far. In the present invention, It is intended to provide patient nutrition.

The technical objects to be achieved by the present invention are not limited to the technical matters mentioned above, and other technical subjects which are not mentioned can be clearly understood by those skilled in the art from the description of the present invention .

The present invention relates to a patient nutrition formula for diarrhea suppression comprising dietary fiber.

Preferably, the dietary fiber is characterized by being a soybean fiber and an oat fiber.

More preferably, the soybean fiber is 0.5 to 1.2 wt%, and the oat fiber is 0.2 to 0.8 wt%. Even more preferably, it may further comprise 6 to 15% by weight of an indigestible maltodextrin and 0.04 to 0.1% by weight of magnesium chloride (MgCl2 · 6H2O).

(1) a first step of adding 0.1 to 0.3% by weight of potassium citrate and 0.06 to 0.10% by weight of sodium citrate as an acidity adjusting agent to 70 to 80% by weight of purified water, and adjusting the pH to 5.5 to 7.5; (2) 0.01 to 0.5 wt% of sorbitan fatty acid ester as an emulsifying agent, 1 to 10 wt% of casein sodium, 1 to 12 wt% of isolated soybean protein, 2.0 to 4.5 wt% of seed oil, 0.2 to 2.5 wt% of MCT- A second step of adding further; And (3) a third step of further adding 0.5 to 1.2 wt% of soybean fiber, 0.2 to 0.8 wt% of oatsfat, 6 to 15 wt% of maltodextrin, and 0.04 to 0.1 wt% of magnesium chloride (MgCl2.6H2O) The present invention relates to a method for producing a patient nutrition formula for diarrhea suppression.

The advantageous effect of the present invention is recognized in that the deterioration of the disease can be prevented by dehydration and nutritional imbalance of the patient due to the existing patient nutrition formula in which the diarrheal incidence is high. Further, according to the present invention, diarrhea suppressing effects can be recognized in emergency patients, intensive care patients, and high-risk patients, and nutritional nutritional supplements with high nutritional value can be provided, and the industrial impact will be substantially high.

1 is a schematic view of a manufacturing method of the present invention.

The present invention relates to a patient nutrition formula for diarrhea suppression comprising dietary fiber.

Preferably, the dietary fiber is characterized by being a soybean fiber and an oat fiber.

More preferably, the soybean fiber is 0.5 to 1.2 wt%, and the oat fiber is 0.2 to 0.8 wt%. Even more preferably, it may further comprise 6 to 15% by weight of an indigestible maltodextrin and 0.04 to 0.1% by weight of magnesium chloride (MgCl2 · 6H2O).

The present invention also relates to a method for preparing an aqueous solution, comprising the steps of: (1) adjusting pH to 5.5 to 7.5 by adding potassium citrate 0.1 to 0.3 wt% and citric acid tin oxide 0.06 to 0.10 wt% as an acidity adjusting agent to 70 to 80 wt% of purified water; (2) 0.01 to 0.5 wt% of sorbitan fatty acid ester as an emulsifying agent, 1 to 10 wt% of casein sodium, 1 to 12 wt% of isolated soybean protein, 2.0 to 4.5 wt% of seed oil, 0.2 to 2.5 wt% of MCT- A second step of adding further; And (3) a third step of further adding 0.5 to 1.2 wt% of soybean fiber, 0.2 to 0.8 wt% of oatsfat, 6 to 15 wt% of maltodextrin, and 0.04 to 0.1 wt% of magnesium chloride (MgCl2.6H2O) The present invention relates to a method for producing a patient nutrition formula for diarrhea suppression.

It is also an aspect of the present invention to add dietary minerals and vitamins, preferably one step further to diarrhea suppression to improve nutritional status.

In the experiments of the present invention, Oat fi bers used products from SunOpta (http://www.sunopta.com/) (see Figure 2), soybean fiber was purchased from The Solae Company ) Were used. However, in the present invention, it is possible to apply oat fiber and soybean fiber, which are usually used in the food industry, and the application aspect of the present invention is not limited to a specific product.

Hereinafter, a particularly advantageous effect will be described based on experimental examples in which data is described for the present invention.

1. Experimental Method

(1) Executing agency: Kyunghee University Hospital nutrition team (2010 clinical data)

(2) Subjects: 20 adult patients who were prescribed the nutritional formula

(3) Experimental design

2) Insoluble fiber group (IF group, n = 12) and insoluble fiber group (SIF group, n = 8)

The insoluble fiber group is a group administered with the diarrhea-suppressing patient nutrition formula prepared according to the production method of the present invention. The mixed fibrinolytic group is a patient nutrition formula with the addition of soluble fiber (IMO (Isomaltooligo saccharide) and FOS (Fructooligo saccharide)) in place of insoluble fiber, soybean fiber and oat fiber.

(4) Supply period: 7 days

(5) Questionnaire method: The number of bowel movements, defecation score (King 's Stool Chart, diarrhea in case of 15 points or more) and gastrointestinal symptoms were examined daily by a clinical nutritionist. The results were analyzed by t-test (p <0.05).

Although the present invention has been described in connection with the specific embodiments of the present invention, it is to be understood that the present invention is not limited thereto. It will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the spirit and scope of the invention as defined by the appended claims. In addition, the materials of each component described herein can be readily selected and substituted for various materials known to those skilled in the art. Those skilled in the art will also appreciate that some of the components described herein can be omitted without degrading performance or adding components to improve performance. In addition, those skilled in the art may change the order of the method steps described herein depending on the process environment or equipment. Therefore, the scope of the present invention should be determined by the appended claims and equivalents thereof, not by the embodiments described.

Claims (3)

Patient nutrition formula Weaning formula using soybean ginseng containing 0.5 ~ 1.2wt% of soybean fiber and 0.2 ~ 0.8wt% of oat fiber. The method according to claim 1,
And 6 to 15 wt% of indomitable maltodextrin and 0.04 to 0.1 wt% of magnesium chloride (MgCl2 · 6H2O). (1) a first step of adding 0.1 to 0.3% by weight of potassium citrate and 0.06 to 0.10% by weight of sodium citrate as an acidity adjusting agent to 70 to 80% by weight of purified water, and adjusting the pH to 5.5 to 7.5;
(2) 0.01 to 0.5 wt% of sorbitan fatty acid ester as an emulsifying agent, 1 to 10 wt% of casein sodium, 1 to 12 wt% of isolated soybean protein, 2.0 to 4.5 wt% of seed oil, 0.2 to 2.5 wt% of MCT- A second step of adding further; And
(3) a third step of adding 0.5 to 1.2 wt% of soybean fiber, 0.2 to 0.8 wt% of oatsfat, 6 to 15 wt% of maltodextrin and 0.04 to 0.1 wt% of magnesium chloride (MgCl2 · 6H2O) Production method of baby foods using wild ginseng.

Images